Le Lézard
Classified in: Health
Subject: MAT

IM Cannabis to Host a Live Investor Webcast on December 10, 2019


TORONTO and GLIL YAM, Israel, Dec. 4, 2019 /CNW/ - IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), one of the world's pioneering medical cannabis companies with operations across Europe,  is pleased to announce that Oren Shuster, Chief Executive Officer, will present live at Grit Capital's Webcast Series on December 10, 2019 at 11:00am ET/8:00am PT.

Date:

December 10, 2019

Time:

11:00am ET/8:00am PT

Format:

Live 20 minutes presentation & 10 minutes Q&A session

Link:

https://event.on24.com/wcc/r/2137262/16F9A018E6438E7C82E6E26986BD239C

 

This will be a live and interactive online event where investors are invited to ask the Company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Recent Company Highlights

About IM Cannabis Corp.

IMC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMC is establishing a medical cannabis operation first with its distribution subsidiary in Germany and augmented by strategic agreements with certified EU-GMP Standard suppliers, making it one of the only medical cannabis companies with fully integrated operations in Europe. IMC intends to leverage its operational experience and brand to establish a foothold in emerging medical cannabis markets including Germany, Portugal and Greece. IMC's core Israeli business includes offering branding, know-how and other intellectual property-related services to the Israeli medical cannabis market. Its key assets in Israel include commercial agreements with licensed producers and an option to purchase licensed entities. IMC has developed proprietary processes in its operations and is active in developing innovative technology for global medical cannabis consumers.

SOURCE IM Cannabis Corp.


These press releases may also interest you

at 20:13
Tocagen Inc. , and Forte Biosciences, Inc., a privately held clinical-stage biopharmaceutical company developing a live biotherapeutic for the treatment of inflammatory skin diseases, announced today that they have entered into a definitive agreement...

at 20:05
Hemostemix Inc. ("Hemostemix" or the "Company") is pleased to announce that it is proceeding with its non-brokered private placement of units, as announced January 2, 2020 (the "Unit Offering"). In addition, the Company announces it is also...

at 19:55
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the pricing of an underwritten public offering of 4,642,857 shares of its common...

at 19:32
Brandon M. Lingenfelter, DO, PhD, is being recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine in appreciation of his role as an OB-GYN at his private practice and Princeton Community Hospital.      Located at...

at 19:32
Abier A. Abdelnaby, MD, is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as a Colorectal Surgeon at the University of Texas Southwestern Medical Center. Located in the southwestern medical district...

at 19:32
Joann Somers, MD, is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as an Obstetrician and Gynecologist at her Private Practice. Located at 22 Old Short Hills Road, Suite 204, Dr. Somers' office...



News published on 4 december 2019 at 07:00 and distributed by: